Bicocca Open Archive

Logo unimib boa
OGGIONI, NORBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.323
AS - Asia 5.983
EU - Europa 5.704
SA - Sud America 785
AF - Africa 96
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 21
Totale 23.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.019
SG - Singapore 2.247
CN - Cina 1.685
DE - Germania 1.038
HK - Hong Kong 941
RU - Federazione Russa 927
SE - Svezia 867
IE - Irlanda 676
IT - Italia 666
BR - Brasile 650
UA - Ucraina 551
VN - Vietnam 410
GB - Regno Unito 329
CA - Canada 232
FI - Finlandia 146
IN - India 138
FR - Francia 122
AT - Austria 115
KR - Corea 114
ID - Indonesia 87
DK - Danimarca 67
JP - Giappone 65
AR - Argentina 64
BD - Bangladesh 56
TR - Turchia 53
ZA - Sudafrica 51
MX - Messico 48
NL - Olanda 46
PL - Polonia 39
ES - Italia 31
IR - Iran 26
IQ - Iraq 25
EC - Ecuador 24
MY - Malesia 23
BE - Belgio 21
NZ - Nuova Zelanda 19
AU - Australia 18
EU - Europa 18
LT - Lituania 17
EG - Egitto 16
SA - Arabia Saudita 14
KZ - Kazakistan 13
PY - Paraguay 12
PK - Pakistan 11
AE - Emirati Arabi Uniti 9
CO - Colombia 9
CZ - Repubblica Ceca 9
UY - Uruguay 9
JO - Giordania 7
KE - Kenya 7
UZ - Uzbekistan 7
BG - Bulgaria 6
DO - Repubblica Dominicana 6
IL - Israele 6
VE - Venezuela 6
AL - Albania 5
BH - Bahrain 5
CL - Cile 5
HR - Croazia 5
MA - Marocco 5
NP - Nepal 5
OM - Oman 5
PA - Panama 5
TN - Tunisia 5
AZ - Azerbaigian 4
HU - Ungheria 4
PE - Perù 4
TT - Trinidad e Tobago 4
CH - Svizzera 3
JM - Giamaica 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
AF - Afghanistan, Repubblica islamica di 2
BY - Bielorussia 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
MD - Moldavia 2
PH - Filippine 2
PT - Portogallo 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TO - Tonga 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BO - Bolivia 1
CG - Congo 1
CY - Cipro 1
DZ - Algeria 1
GR - Grecia 1
Totale 23.943
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.879
Singapore 1.412
Hong Kong 919
Woodbridge 819
Ashburn 809
Chandler 706
Dublin 654
Jacksonville 547
Houston 534
Fairfield 456
Frankfurt am Main 453
Wilmington 448
Dearborn 424
Dallas 334
New York 324
Milan 263
Santa Clara 258
Beijing 254
Princeton 244
Seattle 180
Nanjing 177
Boardman 171
Los Angeles 164
Cambridge 137
Shanghai 132
Hefei 119
Vienna 109
Ho Chi Minh City 103
Lachine 89
Buffalo 82
Chicago 82
Dong Ket 78
The Dalles 78
Guangzhou 76
Moscow 74
Altamura 73
Lawrence 71
Jakarta 69
Seoul 60
Nanchang 59
Munich 54
Council Bluffs 53
Hanoi 52
São Paulo 50
Toronto 49
Fremont 45
Shenyang 43
Andover 42
Grafing 40
Jinan 40
Jiaxing 36
Zhengzhou 34
Nürnberg 33
San Diego 32
Changsha 30
Tianjin 30
Helsinki 29
Rio de Janeiro 29
Tokyo 29
Phoenix 27
Brooklyn 26
Columbus 26
Falls Church 26
Montreal 26
Ottawa 26
Johannesburg 25
Pune 25
Daejeon 24
Denver 24
Hangzhou 24
Kunming 24
London 23
Mountain View 23
Hebei 22
Nuremberg 22
Ankara 20
Brussels 20
Sacramento 20
Orem 19
Turku 19
Warsaw 19
Atlanta 18
Philadelphia 18
Boston 17
Chennai 17
Leawood 16
Mexico City 16
Ningbo 16
Rome 16
Stockholm 16
Poplar 15
Edmonton 13
Huizen 13
Vilnius 13
Bergamo 12
Carate Brianza 12
Da Nang 12
Dhaka 12
Norwalk 12
Pasir Mas 12
Totale 15.456
Salva come PNG Salva come JPEG
Nome #
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 417
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 384
Human Intravenous Immunoglobulin Alleviates Neuropathic Symptoms in a Rat Model of Paclitaxel-Induced Peripheral Neurotoxicity 376
Age-related changes in the function and structure of the peripheral sensory pathway in mice 367
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 365
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 365
Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity 329
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 313
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 312
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 306
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 300
Effect on the peripheral nervous system of systemically administered dimethylsulfoxide in the rat: a neurophysiological and pathological study 277
Bortezomid-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat. 273
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 270
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 268
Neuronopathies and polyneuropathies: a ready to use translational neurophysiological protocol in rodent models 267
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 265
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 264
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 263
Lowering plasma 1-deoxysphingolipids improves neuropathy in diabetic rats 258
The validation of neuroactive drug selection based on combinatorial screening in bortezomib-induced neurotoxicity models. 256
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 255
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 251
Effects of Islet Transplantation and Mesenchymal Stem Cell Co-Transplantation in the Protection of Diabetic Neuropathy in Streptozotocin-Induced Diabetic Rats 251
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 247
Assessment of oxaliplatin-induced peripheral neurotoxicity with different treatment schedules 245
Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth 244
Nerve Excitability Testing to Unravel Chemotherapy Induced Peripheral Neurotoxicity (CIPN) Pathogenesis: Altered Axonal Excitability as a Possible Pivotal Event Related to Platinum Compounds and Taxanes 244
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 238
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 238
Sensory-motor paclitaxel polyneuropathy characterization in a rat model 235
Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity 229
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 228
Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain 226
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 226
Bortezomib-induced peripheral neurotoxicity: A neurophysiological study in a rat model 223
Experimental epothilone B neurotoxicity: Results of in vitro and in vivo studies 218
Distribution of paclitaxel within the nervous system of the rat after repeated intravenous administration 217
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 216
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 216
Cisplatin-induced peripheral neurotoxicity in rats reduces the circulating levels of nerve growth factor 215
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 215
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 215
Macrophage infiltration in different preclinical models of chemotherapy-induced peripheral neurotoxicity 214
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 213
Effects of pixantrone on immune-cell function in the course of acute rat experimental allergic encephalomyelitis 212
Toward the identification of neuroprotective agents: G-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist 211
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 207
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 207
Immunomodulating effects of extracorporeal photochemotherapy in rat experimental allergic encephalomyelitis 206
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 204
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 204
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 203
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 203
Multimodal experimental approach to the study of human neurological diseases 203
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 200
Lipoplatin tm: a less neurotoxic formulation of cisplatin 200
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 199
Erythropoietin both protects from and reverses experimental diabetic neuropathy 198
Pixantrone (BBR2778) reduces the severity of experimental allergic encephalomyelitis 197
Granulocytes in actively induced Lewis rat EAE 194
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 189
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 187
A new animal model of chemotherapy induced peripheral neurotoxicity : the immunodeficient mouse 186
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 185
Organic cation transporter 2 mRNA expression in dorsal root ganglia neurons 185
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 184
Effect of different chronic treatment modalities on the peripheral neurotoxicity of sagopilone in rats: a multimodal analysis 184
Effect of proteasome inhibition on the central and peripheral nervous system 184
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 181
USING A 3D APPROACH TO DESCRIBE CELL POPULATIONS IN THE RAT DORSAL ROOT GANGLIA 181
Actively induced EAE in Lewis rats: Characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease 180
Characterization of spleen and spinal cord infiltrating lymphocytes during actively induced EAE in Lewis rats. 179
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 178
Regression of diabetic complications by islet transplantation in the rat 177
Myelin structure is unaltered in chemotherapy-induced peripheral neuropathy 177
Pain-related behaviour and analgesic effect of gabapentin in an experimental model of bortezomib-induced neuropathic pain 176
Morphometrical characterization of DRG alterations induced by cisplatin and bortezomib in several mice models 176
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 172
The neuroprotective effect of erythropoietin in docetaxel-induced peripheral neuropathy causes no reduction of antitumor activity in 13762 adenocarcinoma-bearing rats 171
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 171
Multimodal Comparison of Diabetic Neuropathy in Aged Streptozotocin-Treated Sprague–Dawley and Zucker Diabetic Fatty Rats 169
ENDOCANNABINOID SYSTEM IN BORTEZOMIB NEUROTOXICITY 167
DIFFERENT DEGREES OF MACROPHAGE INFILTRATION IN PRECLINICAL MODELS OF ANTITUBULIN AGENTS-INDUCED PERIPHERAL NEUROTOXICITY 167
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 166
Cationic liposomes target sites of acute neuroinflammation in experimental autoimmune encephalomyelitis 163
Biodistrubution and toxicology of two PFCs intravenously injected in rats 163
Neurotoxicity and neuropatic pain induced by Bortezomib:evaluation of peripheral nerve fibres from a clinical to an ultrastructural level 160
STUDY OF THE CALCITONIN GENE-RELATED PEPTIDE-POSITIVE INTRAEPIDERMAL NERVE FIBERS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY 158
Neurotoxicity ad neuropathic pain induced by Bortezomib: evaluation of peripheral nerve fibres from a clinical to an ultrastructural level. 157
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 157
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 156
Cisplatin-induced painful peripheral neuropathy severity is strain-dipendent in mice: dissecting the role of pharmacogenomics. 153
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 152
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 149
Neutrophil contribution and immunoglobulin effect in Dark Agouti Experimental Autoimmune Encephalomyelitis. 147
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 144
L-serine supplementation suppresses the formation of neurotoxic deoxysphingolipids and improves neuropathy in a type 1 diabetic rat model 142
An innovative traslational approach to oxaliplatin induced peripheral neurotoxicity in animal models: nerve excitability testing. 142
Chemotherapy-induced peripheral neuropathy in immunodeficient mice: new useful ready-to-use animal models 140
Totale 21.817
Salva come PNG Salva come JPEG
Categoria #
all - tutte 81.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 81.500
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.426 0 0 0 0 0 197 265 197 205 194 132 236
2021/20221.395 81 139 137 127 96 142 65 76 57 116 102 257
2022/20232.668 297 735 235 260 199 431 34 139 214 30 52 42
2023/20242.035 65 62 79 67 274 536 351 89 101 40 23 348
2024/20254.492 283 607 355 210 350 119 203 169 477 616 416 687
2025/20265.099 1.143 684 911 923 1.173 265 0 0 0 0 0 0
Totale 24.855